Intech Investment Management LLC Sells 2,094 Shares of STERIS plc $STE

Intech Investment Management LLC trimmed its stake in STERIS plc (NYSE:STE) by 11.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,617 shares of the medical equipment provider’s stock after selling 2,094 shares during the period. Intech Investment Management LLC’s holdings in STERIS were worth $3,752,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Cetera Investment Advisers lifted its stake in shares of STERIS by 2.8% during the second quarter. Cetera Investment Advisers now owns 7,195 shares of the medical equipment provider’s stock worth $1,728,000 after buying an additional 196 shares during the period. Creative Planning boosted its position in STERIS by 8.9% in the second quarter. Creative Planning now owns 18,012 shares of the medical equipment provider’s stock valued at $4,327,000 after buying an additional 1,471 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in shares of STERIS by 7.2% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 24,097 shares of the medical equipment provider’s stock valued at $5,789,000 after acquiring an additional 1,628 shares during the last quarter. Advisors Capital Management LLC grew its position in STERIS by 11.1% during the 2nd quarter. Advisors Capital Management LLC now owns 3,404 shares of the medical equipment provider’s stock worth $818,000 after purchasing an additional 339 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey boosted its position in STERIS by 4.2% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 14,946 shares of the medical equipment provider’s stock worth $3,590,000 after purchasing an additional 608 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Performance

NYSE:STE opened at $257.15 on Wednesday. STERIS plc has a 1-year low of $200.98 and a 1-year high of $268.30. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53. The firm’s fifty day moving average price is $246.32 and its 200 day moving average price is $240.93. The firm has a market cap of $25.24 billion, a price-to-earnings ratio of 39.38 and a beta of 1.02.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.09. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. STERIS had a return on equity of 14.17% and a net margin of 11.61%.During the same period last year, the business posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, sell-side analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th will be paid a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, November 18th. STERIS’s dividend payout ratio is currently 36.21%.

Insider Transactions at STERIS

In other STERIS news, CEO Daniel A. Carestio sold 159 shares of STERIS stock in a transaction on Monday, October 6th. The shares were sold at an average price of $241.82, for a total value of $38,449.38. Following the transaction, the chief executive officer owned 51,096 shares in the company, valued at $12,356,034.72. This trade represents a 0.31% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP John Adam Zangerle sold 15,000 shares of STERIS stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total value of $3,977,100.00. Following the completion of the transaction, the vice president directly owned 33,669 shares in the company, valued at $8,926,998.66. This represents a 30.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.07% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on STE. KeyCorp upped their target price on STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 22nd. Morgan Stanley boosted their price target on shares of STERIS from $276.00 to $295.00 and gave the company an “overweight” rating in a research report on Friday, August 8th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research note on Tuesday, October 14th. Finally, Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 14th. Seven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $273.50.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.